The Transition From Hypertension to Heart Failure: Contemporary Update
- PMID: 28711447
- DOI: 10.1016/j.jchf.2017.04.012
The Transition From Hypertension to Heart Failure: Contemporary Update
Erratum in
-
Correction.JACC Heart Fail. 2017 Dec;5(12):948. doi: 10.1016/j.jchf.2017.10.007. JACC Heart Fail. 2017. PMID: 29191305 No abstract available.
Abstract
Longstanding hypertension ultimately leads to heart failure (HF), and, as a consequence most patients with HF have a history of hypertension. Conversely, absence of hypertension in middle age is associated with lower risks for incident HF across the remaining life course. Cardiac remodeling to a predominant pressure overload consists of diastolic dysfunction and concentric left ventricular (LV) hypertrophy. When pressure overload is sustained, diastolic dysfunction progresses, filling of the concentric remodeled LV decreases, and HF with preserved ejection fraction ensues. Diastolic dysfunction and HF with preserved ejection fraction are the most common cardiac complications of hypertension. The end stage of hypertensive heart disease results from pressure and volume overload and consists of dilated cardiomyopathy with both diastolic dysfunction and reduced ejection fraction. "Decapitated hypertension" is a term used to describe the decrease in blood pressure resulting from reduced pump function in HF. Progressive renal failure, another complication of longstanding hypertension, gives rise to the cardiorenal syndrome (HF and renal failure). The so-called Pickering syndrome, a clinical entity consisting of flash pulmonary edema and bilateral atheromatous renovascular disease, is a special form of the cardiorenal syndrome. Revascularization of renal arteries is the treatment of choice. Most antihypertensive drug classes when used as initial therapy decelerate the transition from hypertension to HF, although not all of them are equally efficacious. Low-dose, once-daily hydrochlorothiazide should be avoided, but long-acting thiazide-like diuretics chlorthalidone and indapamide seem to have an edge over other antihypertensive drugs in preventing HF.
Keywords: HFpEF; Pickering syndrome; antihypertensive therapy; cardiorenal syndrome; hypertensive heart disease; left ventricular hypertrophy.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Diabetic Hypertensives and Diastolic Dysfunction: Use of Calcium Channel Blockers-A Clinical Concern.JACC Heart Fail. 2017 Nov;5(11):850-851. doi: 10.1016/j.jchf.2017.08.003. JACC Heart Fail. 2017. PMID: 29096795 No abstract available.
-
Reply: Diabetic Hypertensives and Diastolic Dysfunction: Use of Calcium-Channel Blockers-A Clinical Concern.JACC Heart Fail. 2017 Nov;5(11):851. doi: 10.1016/j.jchf.2017.08.022. JACC Heart Fail. 2017. PMID: 29096797 No abstract available.
-
Treatment of Hypertension to Prevent and Treat Heart Failure in Diabetic Patients Should Include Sodium Glucose Co-Transporter 2 Inhibitors.JACC Heart Fail. 2018 Jan;6(1):85. doi: 10.1016/j.jchf.2017.07.008. JACC Heart Fail. 2018. PMID: 29284585 No abstract available.
-
What Is the Ideal Blood Pressure Goal for Heart Failure Patients?JACC Heart Fail. 2018 Oct;6(10):889-890. doi: 10.1016/j.jchf.2018.07.003. JACC Heart Fail. 2018. PMID: 30262117 No abstract available.
-
Reply: What Is the Ideal Blood Pressure Goal for Heart Failure Patients?JACC Heart Fail. 2018 Oct;6(10):890. doi: 10.1016/j.jchf.2018.07.006. JACC Heart Fail. 2018. PMID: 30262119 No abstract available.
Similar articles
-
Diastolic dysfunction: a link between hypertension and heart failure.Drugs Today (Barc). 2008 Jul;44(7):503-13. doi: 10.1358/dot.2008.44.7.1221662. Drugs Today (Barc). 2008. PMID: 18806901 Free PMC article. Review.
-
The current best drug treatment for hypertensive heart failure with preserved ejection fraction.Eur J Intern Med. 2024 Feb;120:3-10. doi: 10.1016/j.ejim.2023.10.008. Epub 2023 Oct 19. Eur J Intern Med. 2024. PMID: 37865559 Review.
-
The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure.Heart Fail Rev. 2020 Jan;25(1):31-42. doi: 10.1007/s10741-019-09855-5. Heart Fail Rev. 2020. PMID: 31512149 Review.
-
Management of hypertension in chronic heart failure.Expert Rev Cardiovasc Ther. 2009 Apr;7(4):423-33. doi: 10.1586/erc.09.8. Expert Rev Cardiovasc Ther. 2009. PMID: 19379066 Review.
-
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.Minerva Cardioangiol. 2002 Jun;50(3):169-74. Minerva Cardioangiol. 2002. PMID: 12107398 Review.
Cited by
-
Advancements in Cardiovascular Disease Research Affected by Smoking.Rev Cardiovasc Med. 2024 Aug 21;25(8):298. doi: 10.31083/j.rcm2508298. eCollection 2024 Aug. Rev Cardiovasc Med. 2024. PMID: 39228476 Free PMC article. Review.
-
Prevalence and correlates of undiagnosed hypertension among staff of a Nigerian university community.Pan Afr Med J. 2022 May 31;42:80. doi: 10.11604/pamj.2022.42.80.26464. eCollection 2022. Pan Afr Med J. 2022. PMID: 36034023 Free PMC article.
-
Exploring Predictive Factors for Heart Failure Progression in Hypertensive Patients Based on Medical Diagnosis Data from the MIMIC-IV Database.Bioengineering (Basel). 2024 May 23;11(6):531. doi: 10.3390/bioengineering11060531. Bioengineering (Basel). 2024. PMID: 38927767 Free PMC article.
-
Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions.Front Pharmacol. 2021 Apr 26;12:665936. doi: 10.3389/fphar.2021.665936. eCollection 2021. Front Pharmacol. 2021. PMID: 33981242 Free PMC article. No abstract available.
-
Heart Failure And Type 2 Diabetes Mellitus: Neurohumoral, Histological And Molecular Interconnections.Curr Cardiol Rev. 2023;19(2):e170622206132. doi: 10.2174/1573403X18666220617121144. Curr Cardiol Rev. 2023. PMID: 35718961 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous